The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge:: Implications for structure-based drug design

被引:112
作者
Greenblatt, HM
Guillou, C
Guénard, D
Argaman, A
Botti, S
Badet, B
Thal, C
Silman, I
Sussman, JL [1 ]
机构
[1] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel
[2] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel
[3] CNRS, Inst Chim Subst Nat, F-91190 Gif Sur Yvette, France
[4] BioStrX Ltd, IL-52656 Ramat Gan, Israel
关键词
D O I
10.1021/ja0466154
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Bifunctional derivatives of the alkaloid galanthamine, designed to interact with both the active site of the enzyme acetylcholinesterase (ACNE) and its peripheral cation binding site, have been assayed with Torpedo californica ACNE (TcAChE), and the three-dimensional structures of their complexes with the enzyme have been solved by X-ray crystallography. Differences were noted between the IC50 values obtained for TcAChE and those for Electrophorus electricus ACNE. These differences are ascribed to sequence differences in one or two residues lining the active-site gorge of the enzyme. The binding of one of the inhibitors disrupts the native conformation of one wall of the gorge, formed by the loop Trp279-Phe290. It is proposed that flexibility of this loop may permit the binding of inhibitors such as galanthamine, which are too bulky to penetrate the narrow neck of the gorge formed by Tyr121 and Phe330 as seen in the crystal structure.
引用
收藏
页码:15405 / 15411
页数:7
相关论文
共 64 条
[1]  
AXELSEN PH, 1994, PROTEIN SCI, V3, P188
[2]   Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine [J].
Bar-On, P ;
Millard, CB ;
Harel, M ;
Dvir, H ;
Enz, A ;
Sussman, JL ;
Silman, I .
BIOCHEMISTRY, 2002, 41 (11) :3555-3564
[3]   Back door opening implied by the crystal structure of a carbamoylated acetylcholinesterase [J].
Bartolucci, C ;
Perola, E ;
Cellai, L ;
Brufani, M ;
Lamba, D .
BIOCHEMISTRY, 1999, 38 (18) :5714-5719
[4]  
Bartolucci C, 2001, PROTEINS, V42, P182, DOI 10.1002/1097-0134(20010201)42:2<182::AID-PROT50>3.0.CO
[5]  
2-1
[6]   THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION [J].
BARTUS, RT ;
DEAN, RL ;
BEER, B ;
LIPPA, AS .
SCIENCE, 1982, 217 (4558) :408-417
[7]   Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease [J].
Bodick, NC ;
Offen, WW ;
Levey, AI ;
Cutler, NR ;
Gauthier, SG ;
Satlin, A ;
Shannon, HE ;
Tollefson, GD ;
Rasmussen, K ;
Bymaster, FP ;
Hurley, DJ ;
Potter, WZ ;
Paul, SM .
ARCHIVES OF NEUROLOGY, 1997, 54 (04) :465-473
[8]   A modular treatment of molecular traffic through the active site of cholinesterase [J].
Botti, SA ;
Felder, CE ;
Lifson, S ;
Sussman, JL ;
Silman, I .
BIOPHYSICAL JOURNAL, 1999, 77 (05) :2430-2450
[9]   Conformational flexibility of the acetylcholinesterase tetramer suggested by X-ray crystallography [J].
Bourne, Y ;
Grassi, J ;
Bougis, PE ;
Marchot, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) :30370-30376
[10]  
Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254